 HINGHAM, Mass., Sept. 13, 2019 GLOBE NEWSWIRE -- Having successfully executed a number of significant milestones over the past twelve months, Microbot Medical Inc. MBOT held its 2019 annual shareholders meeting on September 10, 2019, during which the shareholders re-elected three directors and approved all of the proposals. We have executed many objectives over the past year and at this time our goal remains to achieve our other targeted milestones, including the FDA pre-submission for our Self-Cleaning Shunt SCSTM by the end of this year, commented Harel Gadot, President, CEO and Chairman. At the annual meeting, shareholders approved the reduction of outstanding shares from 221,000,000 to 61,000,000, including a reduction in the number of authorized shares of common stock from 220,000,000 to 60,000,000. 